Annual Report 2021

CONSOLIDATED STATEMENT OF CASH FLOWS For the year ended 31 December 2021 46 The United Laboratories International Holdings Limited Annual Report 2021 2021 2020 RMB’000 RMB’000 Investing activities Payments for purchase of property, plant and equipment (420,251) (514,980) Payment for deposits of acquisition of property, plant and equipment (61,917) (15,775) Receipts of commercial bills receivables 213,905 – Proceeds on disposal of property, plant and equipment 19,164 61,500 Placement of pledged bank deposits (2,551,448) (1,735,053) Withdrawal of pledged bank deposits 2,164,253 2,019,912 Withdrawal of other pledged deposits – 7,423 Interest received 51,594 41,093 Receipts of government grants 2,640 9,454 Receipt of consideration receivables – 300,000 Additions to intangible assets (5,164) (6,815) Net cash (used in) from investing activities (587,224) 166,759 Financing activities Interest paid (50,458) (124,156) Dividends paid (220,847) (128,140) Repayment of lease liabilities (3,045) (1,641) New borrowings raised 1,394,373 2,406,098 Repayment of borrowings (1,709,168) (4,061,196) Net settlement of cross currency interest rate swaps (3,895) (222) Net settlement of foreign currency forwards 13,254 1,658 Payment on repurchase and cancellation of shares (40,978) – Transaction costs attributable to repurchase and cancellation of shares (162) – Net cash used in financing activities (620,926) (1,907,599) Net increase (decrease) in cash and cash equivalents 334,401 (173,014) Effect of foreign exchange rate changes (194) 4,997 Cash and cash equivalents at beginning of the year 2,996,802 3,164,819 Cash and cash equivalents at end of the year 3,331,009 2,996,802